Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women not always linked to increased oil production; other factors may be involved.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Anabolic steroid users may face higher risk of severe COVID-19.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

New treatments for PCOS focus on managing symptoms and improving fertility.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.